Effect of linoleic acid on proliferation and gene expression in the breast cancer cell line T47D

Cancer Letters

Volumn 209, Issue 1, 2004, Pages 25-35

  Reyes, Niradiz ^a,b   Reyes, Ismael ^a   Tiwari, Raj ^a   Geliebter, Jan ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Rafael Nuñez University   (Colombia)

Author keywords

Breast cancer; Linoleic acid; Microarray

Indexed keywords

ESTROGEN RECEPTOR ALPHA; GUANINE NUCLEOTIDE BINDING PROTEIN; LINOLEIC ACID; MITOGEN ACTIVATED PROTEIN KINASE P38;

ADULT; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REGULATORY MECHANISM; RNA TRANSCRIPTION;

CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEIN ALPHA SUBUNITS, G12-G13; HUMANS; LINOLEIC ACID; MITOGEN-ACTIVATED PROTEIN KINASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; S PHASE; TRANSCRIPTION, GENETIC; UP-REGULATION;

ANIMALIA;

EID: 2442515563     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.12.010     Document Type: Article

References (44)

1. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M. Cancer statistics, 2003. CA Cancer J. Clin. 53:2003;5-26
2. Coffey D.S. Similarities of prostate and breast cancer: Evolution, diet, and estrogens. Urology. 57:2001;31-38
3. Yonemoto R.H. Breast cancer in Japan and United States: epidemiology, hormone receptors, pathology, and survival. Arch. Surg. 115:1980;1056-1062
4. Willett W. Lessons from dietary studies in Adventists and questions for the future. Am. J. Clin. Nutr. 78:2003;539S-543S
5. Rock C.L. Diet and breast cancer: can dietary factors influence survival? J. Mammary Gland Biol. Neoplasia. 8:2003;119-132
6. Richter W.O. Fatty acids and breast cancer - is there a relationship? Eur. J. Med. Res. 8:2003;373-380
7. Forman M.R., Ballard-Barbash R., Kipnis V. Nutritional strategies for breast cancer prevention: what have we learned and where do we go from here? Cancer. 98:2003;1782-1785
8. Boyd N.F., Stone J., Vogt K.N., Connelly B.S., Martin L.J., Minkin S. Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature. Br. J. Cancer. 89:2003;1672-1685
9. Welsch C.W. Relationship between dietary fat and experimental mammary tumorigenesis: a review and critique. Cancer Res. 52:1992;2040s-2048s
10. Fay M.P., Freedman L.S., Clifford C.K., Midthune D.N. Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review. Cancer Res. 57:1997;3979-3988
11. Noguchi M., Taniya T., Kumaki T., Ohta N., Kitagawa H., Kinoshita K., Earashi M., Yagasaki R., Minami M., Kawahara F., Tsuyama H., Miwa K. Dietary fat and breast cancer: a controversial issue. Breast Cancer. 4:1997;67-75
12. Lee M.M., Lin S.S. Dietary fat and breast cancer. Annu. Rev. Nutr. 20:2000;221-248
13. Jump D.B., Clarke S.D. Regulation of gene expression by dietary fat. Annu. Rev. Nutr. 19:1999;63-90
14. Chalbos D., Joyeux C., Galtier F., Rochefort H. Progestin-induced fatty acid synthetase in human mammary tumors: from molecular to clinical studies. J. Steroid Biochem. Mol. Biol. 43:1992;223-228
15. Yu H., Berkel H. Insulin-like growth factors and cancer. J. La State Med. Soc. 151:1999;218-223
16. Brown N.S., Bicknell R. Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res. 3:2001;323-327
17. Bartsch H., Nair J., Owen R.W. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers [In Process Citation]. Carcinogenesis. 20:1999;2209-2218
18. Hodgkin M.N., Pettitt T.R., Martin A., Michell R.H., Pemberton A.J., Wakelam M.J. Diacylglycerols and phosphatidates: which molecular species are intracellular messengers? Trends Biochem. Sci. 23:1998;200-204
19. Fleshner N.E., Klotz L.H. Diet, androgens, oxidative stress and prostate cancer susceptibility. Cancer Metastasis Rev. 17:1998;325-330
20. Freake H.C., Marcocci C., Iwasaki J., MacIntyre I. 1, 25-dihydroxyvitamin D3 specifically binds to a human breast cancer cell line (T47D) and stimulates growth. Biochem. Biophys. Res. Commun. 101:1981;1131-1138
21. Dahlquist K.D., Salomonis N., Vranizan K., Lawlor S.C., Conklin B.R. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat. Genet. 31:2002;19-20
22. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J.C., Richardson J.E., Ringwald M., Rubin G.M., Sherlock G. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat. Genet. 25:2000;25-29
23. desBordes C., Lea M.A. Effects of C18 fatty acid isomers on DNA synthesis in hepatoma and breast cancer cells. Anticancer Res. 15:1995;2017-2021
24. Bardon S., Le M.T., Alessandri J.M. Metabolic conversion and growth effects of n-6 and n-3 polyunsaturated fatty acids in the T47D breast cancer cell line. Cancer Lett. 99:1996;51-58
25. Penzo D., Tagliapietra C., Colonna R., Petronilli V., Bernardi P. Effects of fatty acids on mitochondria: implications for cell death. Biochim. Biophys. Acta. 1555:2002;160-165
26. Rose D.P. Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studies. Am. J. Clin. Nutr. 66:1997;1513S-1522S
27. Razanamahefa L., Prouff S., Bardon S. Stimulatory effect of arachidonic acid on T-47D human breast cancer cell growth is associated with enhancement of cyclin D1 mRNA expression. Nutr. Cancer. 38:2000;274-280
28. Qin C., Wilson C., Blancher C., Taylor M., Safe S., Harris A.L. Association of ARNT splice variants with estrogen receptor-negative breast cancer, poor induction of vascular endothelial growth factor under hypoxia, and poor prognosis. Clin. Cancer Res. 7:2001;818-823
29. Ouwens D.M., de Ruiter N.D., van der Zon G.C., Carter A.P., Schouten J., van der Burgt C., Kooistra K., Bos J.L., Maassen J.A., van Dam H. Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38. Eur. Mol. Biol. Org. J. 21:2002;3782-3793
30. Price D.H. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20:2000;2629-2634
31. Prall O.W., Sarcevic B., Musgrove E.A., Watts C.K., Sutherland R.L. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J. Biol. Chem. 272:1997;10882-10894
32. Prall O.W., Rogan E.M., Sutherland R.L. Estrogen regulation of cell cycle progression in breast cancer cells. J. Steroid Biochem. Mol. Biol. 65:1998;169-174
33. Timms J.F., White S.L., O'Hare M.J., Waterfield M.D. Effects of ErbB-2 overexpression on mitogenic signalling and cell cycle progression in human breast luminal epithelial cells. Oncogene. 21:2002;6573-6586
34. Ando S., De Amicis F., Rago V., Carpino A., Maggiolini M., Panno M., Lanzino M. Breast cancer: from estrogen to androgen receptor. Mol. Cell Endocrinol. 193:2002;121
35. Hamel P.A., Hanley-Hyde J. G1 cyclins and control of the cell division cycle in normal and transformed cells. Cancer Invest. 15:1997;143-152
36. Gilman A.G. Nobel lecture. G proteins and regulation of adenylyl cyclase. Biosci. Rep. 15:1995;65-97
37. Neer E.J. Heterotrimeric G proteins: organizers of transmembrane signals. Cell. 80:1995;249-257
38. Dhanasekaran N., Dermott J.M. Signaling by the G12 class of G proteins. Cell Signal. 8:1996;235-245
39. Bandyopadhyay G.K., Imagawa W., Nandi S. Role of GTP-binding proteins in the polyunsaturated fatty acid stimulated proliferation of mouse mammary epithelial cells. Prostaglandins Leukot Essent. Fatty Acids. 52:1995;151-158
40. Sugden P.H., Clerk A. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal. 9:1997;337-351
41. Santen R.J., Song R.X., McPherson R., Kumar R., Adam L., Jeng M.H., Yue W. The role of mitogen-activated protein (MAP) kinase in breast cancer. J. Steroid Biochem. Mol. Biol. 80:2002;239-256
42. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 270:1995;1491-1494
43. Atanaskova N., Keshamouni V.G., Krueger J.S., Schwartz J.A., Miller F., Reddy K.B. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance. Oncogene. 21:2002;4000-4008
44. Natarajan R., Nadler J. Role of lipoxygenases in breast cancer. Front. Biosci. 3:1998;E81-E88